Atlas of expression of acyl CoA binding protein/diazepam binding inhibitor (ACBP/DBI) in human and mouse
Acyl CoA binding protein encoded by diazepam binding inhibitor (ACBP/DBI) is a tissue hormone that stimulates lipo-anabolic responses and inhibits autophagy, thus contributing to aging and age-related diseases. Protein expression profiling of ACBP/DBI was performed on mouse tissues to identify organs in which this major tissue hormone is expressed. Transcriptomic and proteomic data bases corroborated a high level of human-mouse interspecies conservation of ACBP/DBI expression in different organs. Single-cell RNA-seq data confirmed that ACBP/DBI was strongly expressed by parenchymatous cells from specific human and mouse organs (e.g., kidney, large intestine, liver, lung) as well as by myeloid or glial cells from other organs (e.g., adipose tissue, brain, eye) following a pattern that was conserved among the two species. We identified a panel of 44 mRNAs that are strongly co-expressed with ACBP/DBI mRNA in normal and malignant human and normal mouse tissues. Of note, 22 (50%) of these co-expressed mRNAs encode proteins localized at mitochondria, and mRNAs with metabolism-related functions are strongly overrepresented (66%). Systematic data mining was performed to identify transcription factors that regulate ACBP/DBI expression in human and mouse. Several transcription factors, including growth response 1 (EGR1), E2F Transcription Factor 1 (E2F1, which interacts with retinoblastoma, RB) and transformation-related protein 53 (TRP53, best known as p53), which are endowed with oncosuppressive effects, consistently repress ACBP/DBI expression as well as its co-expressed mRNAs across multiple datasets, suggesting a mechanistic basis for a coregulation network. Furthermore, we identified multiple transcription factors that transactivate ACBP/DBI gene expression together with its coregulation network. Altogether, this study indicates the existence of conserved mechanisms determining the expression of ACBP/DBI in specific cell types of the mammalian organism.
Authors
- Flavia Lambertucci (ORCID: https://orcid.org/0000-0002-2719-6635)
- Hui Chen (ORCID: https://orcid.org/0000-0002-1260-8617)
- Yanbing Dong
- Vincent Carbonnier (ORCID: https://orcid.org/0000-0002-2795-5013)
- Sarah Adriana Scuderi (ORCID: https://orcid.org/0000-0001-8566-9739)
- Fatima Domenica Elisa De Palma (ORCID: https://orcid.org/0000-0002-6109-2768)
- Guido Kroemer (ORCID: https://orcid.org/0000-0002-9334-4405)
- Léa Montégut (ORCID: https://orcid.org/0000-0003-4778-4757)
- Isabelle Martins (ORCID: https://orcid.org/0000-0003-0885-613X)
- Maria Chiara Maiuri (ORCID: https://orcid.org/0000-0001-9760-7674)
- Rong Yan (ORCID: https://orcid.org/0000-0002-8648-0636)
- Sijing Li (ORCID: https://orcid.org/0000-0002-4354-7167)
- Silvia Mingoia
Institutions
- University of Messina (IT)
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- Inserm (FR)
- Institut Universitaire de France (FR)
- Université Paris Cité (FR)
- Université Paris-Saclay (FR)
- Institut Gustave Roussy (FR)
- Sorbonne Université (FR)
- Sorbonne Paris Cité (FR)
- Centre de Recherche des Cordeliers (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Européen Georges-Pompidou (FR)
- Hôpital Européen (FR)
- Federico II University Hospital (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Cell Death and Disease
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1038/s41419-025-07447-w
- Citations
- 5
- Primary Topic
- Peroxisome Proliferator-Activated Receptors
- Type
- article
- Field-Weighted Citation Impact
- 4.03
Funders
- Agence Nationale de la Recherche